SEQENS is a global leader in the pharmaceutical industry, with over 30 years’ experience in the development and manufacturing of APIs, intermediates and polymers.

Seqens’ state-of-the-art R&D facilities in Europe and in the US, along with its network of 8 manufacturing sites (GMP and non‑GMP), enable the company to innovate, develop and industrialize the most demanding molecules and implement the best available technologies.

Seqens supports its customers from early‑stage development to commercial production, offering tailored solutions for complex molecules.

As a trusted partner to over 1,000 customers worldwide, Seqens is backed by a strong CMC project management team, offering the highest level of service and commitment.